Trans effect
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
In inorganic chemistry, the trans effect is the labilization of ligands trans to certain other ligands, which can thus be regarded as trans directing ligands. It is attributed to electronic effects and it is most notable in square planar complexes, although it can also be observed for octahedral complexes.[1]
In addition to this kinetic trans effect, trans ligands also have an influence on the ground state of the molecule, notably on bond lengths and stability. Some authors prefer the term trans influence to distinguish it from the kinetic effect,[1] while others use more specific terms such as structural trans effect or thermodynamic trans effect.[1]
The discovery of the trans effect is attributed to Ilya Ilich Chernyaev,[1] who recognized it and gave it a name in 1926.[1]
Kinetic trans effect
The intensity of the trans effect (as measured by the increase in rate of substitution of the trans ligand) follows this sequence:
F−, H2O, OH− < NH3 < py < Cl− < Br− < I−, SCN−, NO2−, SC(NH2)2, Ph− < SO32− < PR3, AsR3, SR2, CH3− < H−, NO, CO, CN− C2H4
The classic example of the trans effect is the synthesis of cisplatin. Starting from PtCl42−, the first NH3 ligand is added to any of the four equivalent positions at random, but the second NH3 is added cis to the first one, because Cl− has a larger trans effect than NH3. If, on the other hand, one starts from Pt(NH3)42+, the trans product is obtained instead.
The trans effect in square complexes can be explained in terms of an addition/elimination mechanism that goes through a trigonal bipyramidal intermediate. Ligands with a high trans effect are generally those with high π acidity (as in the case of phosphines) or low ligand lone pair–dπ repulsions (as in the case of hydride), which prefer the more π-basic equatorial sites in the intermediate. The second equatorial position is occupied by the incoming ligand; due to the principle of microscopic reversibility, the departing ligand must also leave from an equatorial position. The third and final equatorial site is occupied by the trans ligand, so the net result is that the kinetically favored product is the one where the ligand trans to the one with the largest trans effect is eliminated.[1]
Structural trans effect
The structural trans effect can be measured experimentally using X-ray crystallography, and is observed as a stretching of the bonds between the metal and the ligand trans to a trans-influencing ligand. Stretching by as much as 0.2 Å occurs with strong trans-influencing ligands such as hydride. A cis influence can also be observed, but is smaller than the trans influence. The relative importance of the cis and trans influences depends on the formal electron configuration of the metal center, and explanations have been proposed based on the atomic orbitals involved.[1]
References
Further reading
- Quagliano, J. V.; Schubert, Leo. The Trans Effect in Complex Inorganic Compounds. Chem. Rev. 1952, 50, 201-260.
- Basolo, F. The trans effect in metal complexes. Prog. Inorg. Chem. 1962, 4, 381-453.
- Hartley, F. R. The cis- and trans-effects of ligands. Chem. Soc. Rev. 1973, 2, 163-179. doi:10.1039/CS9730200163
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
